SNX9 Antikörper (AA 85-200) (HRP)
-
- Target Alle SNX9 Antikörper anzeigen
- SNX9 (Sorting Nexin 9 (SNX9))
-
Bindungsspezifität
- AA 85-200
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SNX9 Antikörper ist konjugiert mit HRP
-
Applikation
- ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Sorting nexin-9 protein (85-200AA)
- Isotyp
- IgG
- Top Product
- Discover our top product SNX9 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- SNX9 (Sorting Nexin 9 (SNX9))
- Andere Bezeichnung
- SNX9 (SNX9 Produkte)
- Synonyme
- si:bz36d5.4 antikoerper, snx9 antikoerper, zgc:113455 antikoerper, MGC78823 antikoerper, SNX9 antikoerper, SDP1 antikoerper, SH3PX1 antikoerper, SH3PXD3A antikoerper, WISP antikoerper, 2700073N08Rik antikoerper, sorting nexin 9a antikoerper, sorting nexin 9 antikoerper, sorting nexin 9 L homeolog antikoerper, snx9a antikoerper, SNX9 antikoerper, snx9.L antikoerper, snx9 antikoerper, Snx9 antikoerper
- Hintergrund
-
Background: Involved in endocytosis and intracellular vesicle trafficking, both during interphase and at the end of mitosis. Required for efficient progress through mitosis and cytokinesis. Required for normal formation of the cleavage furrow at the end of mitosis. Plays a role in endocytosis via clathrin-coated pits, but also clathrin-independent, actin-dependent fluid-phase endocytosis. Plays a role in macropinocytosis. Promotes internalization of TNFR. Promotes degradation of EGFR after EGF signaling. Stimulates the GTPase activity of DNM1. Promotes DNM1 oligomerization. Promotes activation of the Arp2/3 complex by WASL, and thereby plays a role in the reorganization of the F-actin cytoskeleton. Binds to membranes enriched in phosphatidylinositol 4,5-bisphosphate and promotes membrane tubulation. Has lower affinity for membranes enriched in phosphatidylinositol 3-phosphate.
Aliases: MST 155 antibody, MST155 antibody, MSTP 155 antibody, MSTP155 antibody, OTTHUMP00000040083 antibody, Protein SDP 1 antibody, Protein SDP1 antibody, SDP 1 antibody, SDP1 antibody, SH3 and PX domain containing protein 3A antibody, SH3 and PX domain containing protein SH3PX1 antibody, SH3 and PX domain-containing protein 1 antibody, SH3 and PX domain-containing protein 3A antibody, SH3PX1 antibody, SH3PXD3A antibody, SNX 9 antibody, SNX9 antibody, SNX9_HUMAN antibody, Sorting nexin 9 antibody, Sorting nexin-9 antibody, WASP interactor protein antibody, Wiskott Aldrich syndrome protein (WASP) interactor protein antibody, Wiskott Aldrich syndrome protein interactor protein antibody, WISP antibody
- UniProt
- Q9Y5X1
-